Envoy Medical (COCH) Operating Expenses (2021 - 2026)

Envoy Medical has disclosed Operating Expenses across 6 years of filings, most recently posting $5.6 million for Q2 2026.

• In Q2 2026, Operating Expenses rose 9.17% year-over-year to $5.6 million; the TTM figure through Jun 2026 stood at $23.8 million (up 19.62% YoY), while the FY2025 annual figure was $22.5 million, up 15.55% from the prior year.
• Operating Expenses came in at $5.6 million for Q2 2026 at Envoy Medical, down from $6.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $6.8 million in Q4 2023 to a low of $901356.0 in Q2 2022.
• Average Operating Expenses over 5 years is $4.4 million, with a median of $4.9 million recorded in 2024.
• Year-over-year, Operating Expenses slumped 37.95% in 2022 and soared 404.02% in 2023.
• Over 5 years, Operating Expenses stood at $2.9 million in 2022, then soared by 133.01% to $6.8 million in 2023, then plunged by 32.66% to $4.6 million in 2024, then jumped by 40.71% to $6.5 million in 2025, then dropped by 13.0% to $5.6 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $5.6 million in Q2 2026, $6.0 million in Q1 2026, and $6.5 million in Q4 2025.